1 Graus, F. et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet. Neurology15, 391-404, doi:10.1016/S1474-4422(15)00401-9 (2016).
2 Titulaer, M. J. et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet. Neurology12, 157-165, doi:10.1016/S1474-4422(12)70310-1 (2013).
3 Broadley, J. et al. Prognosticating autoimmune encephalitis: A systematic review. J Autoimmun96, 24-34, doi:10.1016/j.jaut.2018.10.014 (2019).
4 Squizzato, A., Gerdes, V. E., Brandjes, D. P., Buller, H. R. & Stam, J. Thyroid diseases and cerebrovascular disease. Stroke36, 2302-2310, doi:10.1161/01.STR.0000181772.78492.07 (2005).
5 Meyer, S. et al. Low triiodothyronine syndrome: a prognostic marker for outcome in sepsis? Endocrine39, 167-174, doi:10.1007/s12020-010-9431-4 (2011).
6 Iervasi, G. et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation107, 708-713, doi:10.1161/01.cir.0000048124.64204.3f (2003).
7 Scoscia, E. et al. Low triiodothyronine (T3) state: a predictor of outcome in respiratory failure? Results of a clinical pilot study. Eur J Endocrinol151, 557-560, doi:10.1530/eje.0.1510557 (2004).
8 Suda, S. et al. Low free triiodothyronine predicts poor functional outcome after acute ischemic stroke. Journal of the neurological sciences368, 89-93, doi:10.1016/j.jns.2016.06.063 (2016).
9 Tektonidou, M. G., Anapliotou, M., Vlachoyiannopoulos, P. & Moutsopoulos, H. M. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis63, 1159-1161, doi:10.1136/ard.2004.022624 (2004).
10 Cho, E. B. et al. Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability. Journal of the neurological sciences370, 214-218, doi:10.1016/j.jns.2016.09.039 (2016).
11 Bernal, J. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab3, 249-259, doi:10.1038/ncpendmet0424 (2007).
12 Desouza, L. A. et al. Thyroid hormone regulates hippocampal neurogenesis in the adult rat brain. Molecular and cellular neurosciences29, 414-426, doi:10.1016/j.mcn.2005.03.010 (2005).
13 Lin, Y. et al. Anti-thyroid antibodies and thyroid function in anti-N-methyl-d-aspartate receptor encephalitis. Neurochemistry international113, 107-111, doi:10.1016/j.neuint.2017.11.019 (2018).
14 Ma, X. et al. Thyroid Function and Autoimmune Indications in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Neuroimmunomodulation25, 110-117, doi:10.1159/000492179 (2018).
15 Plikat, K. et al. Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism56, 239-244, doi:10.1016/j.metabol.2006.09.020 (2007).
16 Bunevicius, A. et al. Low triiodothyronine syndrome as a predictor of poor outcomes in patients undergoing brain tumor surgery: a pilot study: clinical article. J Neurosurg118, 1279-1287, doi:10.3171/2013.1.JNS121696 (2013).
17 Ambrogini, P. et al. Thyroid hormones affect neurogenesis in the dentate gyrus of adult rat. Neuroendocrinology81, 244-253, doi:10.1159/000087648 (2005).
18 De Vito, P. et al. Nongenomic effects of thyroid hormones on the immune system cells: New targets, old players. Steroids77, 988-995, doi:10.1016/j.steroids.2012.02.018 (2012).
19 van der Spek, A. H., Fliers, E. & Boelen, A. Thyroid hormone metabolism in innate immune cells. J Endocrinol232, R67-R81, doi:10.1530/JOE-16-0462 (2017).
20 Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R. & Balice-Gordon, R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet. Neurology10, 63-74, doi:10.1016/S1474-4422(10)70253-2 (2011).
21 Venkatesan, A. & Adatia, K. Anti-NMDA-Receptor Encephalitis: From Bench to Clinic. ACS Chem Neurosci8, 2586-2595, doi:10.1021/acschemneuro.7b00319 (2017).
22 Mendes-de-Aguiar, C. B. et al. Thyroid hormone increases astrocytic glutamate uptake and protects astrocytes and neurons against glutamate toxicity. Journal of neuroscience research86, 3117-3125, doi:10.1002/jnr.21755 (2008).
23 Cheng, S. Y., Leonard, J. L. & Davis, P. J. Molecular aspects of thyroid hormone actions. Endocrine reviews31, 139-170, doi:10.1210/er.2009-0007 (2010).
24 Sui, L., Ren, W. W. & Li, B. M. Administration of thyroid hormone increases reelin and brain-derived neurotrophic factor expression in rat hippocampus in vivo. Brain research1313, 9-24, doi:10.1016/j.brainres.2009.12.010 (2010).
25 Lemkine, G. F. et al. Adult neural stem cell cycling in vivo requires thyroid hormone and its alpha receptor. FASEB J19, 863-865, doi:10.1096/fj.04-2916fje (2005).
26 Peeters, R. P. et al. Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab90, 4559-4565, doi:10.1210/jc.2005-0535 (2005).
27 Boelen, A. et al. Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. J Endocrinol182, 315-323, doi:10.1677/joe.0.1820315 (2004).
28 Weetman, A. P. Autoimmune thyroid disease. Autoimmunity37, 337-340, doi:10.1080/08916930410001705394 (2004).